Gut health has a direct effect on skin health and helps reduce acne and inflammation
To summarize the open-label extension of VESPER-1, berobenatide 2.4 mg weekly demonstrated 16% weight loss at 32 weeks, a favorable benefit-risk profile for monthly dosing, and safety and tolerability consistent with the class with no discontinuations related to gastrointestinal adverse events, and the gastrointestinal tolerability was excellent, said John B
Expect gradual changes in cravings, digestion, and energy rather than overnight weight loss
PMID: 212 MasoudVPagsG
By calling these products GLP-1 patches, companies create the illusion that they are linked to GLP-1 science
In some embodiments, a high viscosity otic formulation or device described herein provides an apparent viscosity of from about 150,000 cP to about 500,000 cP